DEXCOM, INC. Diluted Shares Outstanding (Weighted Average)
DEXCOM, INC. (DXCM) reported Diluted Shares Outstanding (Weighted Average) of 390.10 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-07-30
- DEXCOM, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 390.10M shares, a 4.43% decline year-over-year.
- DEXCOM, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 393.60M shares, a 3.41% decline year-over-year.
- DEXCOM, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 398.90M shares, a 1.92% decline year-over-year.
- DEXCOM, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 407.40M shares, a 0.68% decline year-over-year.
- DEXCOM, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 405.50M shares, a 1.74% decline from fiscal 2024.
- DEXCOM, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 412.70M shares, a 3.01% decline from fiscal 2023.
- DEXCOM, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 425.50M shares, a 0.47% decline from fiscal 2022.
- DEXCOM, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 427.50M shares, a 0.30% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 390.10M shares 10-Q · filed 2026-07-30 | 391.80M shares 10-Q · filed 2026-07-30 | 394.20M shares derived: average of 3 quarters · filed 2026-07-30 | 397.50M shares derived: average of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | 393.60M shares 10-Q · filed 2026-04-30 | 396.25M shares derived: average of 2 quarters · filed 2026-04-30 | 399.97M shares derived: average of 3 quarters · filed 2026-04-30 | 402.02M shares derived: average of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | 398.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | 403.15M shares derived: average of 2 quarters · filed 2026-02-12 | 404.83M shares derived: average of 3 quarters · filed 2026-07-30 | 405.50M shares 10-K · filed 2026-02-12 | ||||
| 2025-09-30 | 407.40M shares 10-Q · filed 2025-10-30 | 407.80M shares derived: average of 2 quarters · filed 2026-07-30 | 407.70M shares 10-Q · filed 2025-10-30 | 407.45M shares derived: average of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | 408.20M shares 10-Q · filed 2026-07-30 | 407.80M shares 10-Q · filed 2026-07-30 | 407.47M shares derived: average of 3 quarters · filed 2026-07-30 | 408.15M shares derived: average of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | 407.50M shares 10-Q · filed 2026-04-30 | 407.10M shares derived: average of 2 quarters · filed 2026-04-30 | 408.13M shares derived: average of 3 quarters · filed 2026-04-30 | 410.30M shares derived: average of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | 406.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | 408.45M shares derived: average of 2 quarters · filed 2026-02-12 | 411.23M shares derived: average of 3 quarters · filed 2026-02-12 | 412.70M shares 10-K · filed 2026-02-12 | ||||
| 2024-09-30 | 410.20M shares 10-Q · filed 2025-10-30 | 413.50M shares derived: average of 2 quarters · filed 2025-10-30 | 414.70M shares 10-Q · filed 2025-10-30 | 415.20M shares derived: average of 4 quarters · filed 2026-02-12 | ||||
| 2024-06-30 | 416.80M shares 10-Q · filed 2025-07-30 | 416.90M shares 10-Q · filed 2025-07-30 | 416.87M shares derived: average of 3 quarters · filed 2026-02-12 | 419.35M shares derived: average of 4 quarters · filed 2026-02-12 | ||||
| 2024-03-31 | 416.70M shares 10-Q · filed 2025-05-01 | 416.90M shares derived: average of 2 quarters · filed 2026-02-12 | 420.20M shares derived: average of 3 quarters · filed 2026-02-12 | 423.02M shares derived: average of 4 quarters · filed 2026-02-12 | ||||
| 2023-12-31 | 417.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | 421.95M shares derived: average of 2 quarters · filed 2026-02-12 | 425.13M shares derived: average of 3 quarters · filed 2026-02-12 | 425.50M shares 10-K · filed 2026-02-12 | ||||
| 2023-09-30 | 426.80M shares 10-Q · filed 2024-10-24 | 429.15M shares derived: average of 2 quarters · filed 2024-10-24 | 428.30M shares 10-Q · filed 2024-10-24 | 425.70M shares derived: average of 4 quarters · filed 2025-02-18 | ||||
| 2023-06-30 | 431.50M shares 10-Q · filed 2024-07-25 | 426.60M shares 10-Q · filed 2024-07-25 | 425.33M shares derived: average of 3 quarters · filed 2025-02-18 | 425.45M shares derived: average of 4 quarters · filed 2025-02-18 | ||||
| 2023-03-31 | 418.50M shares 10-Q · filed 2024-04-25 | 422.25M shares derived: average of 2 quarters · filed 2025-02-18 | 423.43M shares derived: average of 3 quarters · filed 2025-02-18 | 422.93M shares derived: average of 4 quarters · filed 2025-02-18 | ||||
| 2022-12-31 | 426.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | 425.90M shares derived: average of 2 quarters · filed 2025-02-18 | 424.40M shares derived: average of 3 quarters · filed 2025-02-18 | 427.50M shares 10-K · filed 2025-02-18 | ||||
| 2022-09-30 | 425.80M shares 10-Q · filed 2023-10-26 | 423.60M shares derived: average of 2 quarters · filed 2023-10-26 | 428.00M shares 10-Q · filed 2023-10-26 | 426.85M shares derived: average of 4 quarters · filed 2024-02-08 | ||||
| 2022-06-30 | 421.40M shares 10-Q · filed 2023-07-27 | 429.10M shares 10-Q · filed 2023-07-27 | 427.20M shares derived: average of 3 quarters · filed 2024-02-08 | 427.98M shares derived: average of 4 quarters · filed 2024-02-08 | ||||
| 2022-03-31 | 428.70M shares 10-Q · filed 2023-04-27 | 107.20M shares 10-Q · filed 2022-04-28 | 430.10M shares derived: average of 2 quarters · filed 2024-02-08 | 430.17M shares derived: average of 3 quarters · filed 2024-02-08 | 429.40M shares derived: average of 4 quarters · filed 2024-02-08 | |||
| 2021-12-31 | 431.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | 430.90M shares derived: average of 2 quarters · filed 2024-02-08 | 429.63M shares derived: average of 3 quarters · filed 2024-02-08 | 428.80M shares 10-K · filed 2024-02-08 | 100.10M shares 10-K · filed 2022-02-14 | |||
| 2021-09-30 | 430.30M shares 10-Q · filed 2022-10-27 | 100.50M shares 10-Q · filed 2021-10-28 | 428.70M shares derived: average of 2 quarters · filed 2022-10-27 | 427.90M shares 10-Q · filed 2022-10-27 | 99.80M shares 10-Q · filed 2021-10-28 | 588.23M shares derived: average of 4 quarters · filed 2023-02-09 | ||
| 2021-06-30 | 427.10M shares 10-Q · filed 2022-07-28 | 99.60M shares 10-Q · filed 2021-07-29 | 426.80M shares 10-Q · filed 2022-07-28 | 99.50M shares 10-Q · filed 2021-07-29 | 640.87M shares derived: average of 3 quarters · filed 2023-02-09 | 505.52M shares derived: average of 4 quarters · filed 2023-02-09 | ||
| 2021-03-31 | 104.60M shares 10-Q · filed 2022-04-28 | 99.40M shares 10-Q · filed 2021-04-29 | 747.75M shares derived: average of 2 quarters · filed 2023-02-09 | 531.67M shares derived: average of 3 quarters · filed 2023-02-09 | 423.00M shares derived: average of 4 quarters · filed 2023-02-09 | |||
| 2020-12-31 | 1.39B shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | 745.20M shares derived: average of 2 quarters · filed 2023-02-09 | 529.13M shares derived: average of 3 quarters · filed 2023-02-09 | 420.40M shares 10-K · filed 2023-02-09 | 97.50M shares 10-K · filed 2021-02-11 | |||
| 2020-09-30 | 99.50M shares 10-Q · filed 2021-10-28 | 98.25M shares derived: average of 2 quarters · filed 2021-10-28 | 96.90M shares 10-Q · filed 2021-10-28 | 95.80M shares derived: average of 4 quarters · filed 2022-02-14 | ||||
| 2020-06-30 | 97.00M shares 10-Q · filed 2021-07-29 | 95.60M shares 10-Q · filed 2021-07-29 | 94.57M shares derived: average of 3 quarters · filed 2022-02-14 | 94.05M shares derived: average of 4 quarters · filed 2022-02-14 | ||||
| 2020-03-31 | 94.10M shares 10-Q · filed 2021-04-29 | 93.35M shares derived: average of 2 quarters · filed 2022-02-14 | 93.07M shares derived: average of 3 quarters · filed 2022-02-14 | 92.58M shares derived: average of 4 quarters · filed 2022-02-14 | ||||
| 2019-12-31 | 92.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | 92.55M shares derived: average of 2 quarters · filed 2022-02-14 | 92.07M shares derived: average of 3 quarters · filed 2022-02-14 | 92.30M shares 10-K · filed 2022-02-14 | ||||
| 2019-09-30 | 92.50M shares 10-Q · filed 2020-10-27 | 91.80M shares derived: average of 2 quarters · filed 2020-10-27 | 92.20M shares 10-Q · filed 2020-10-27 | 89.70M shares derived: average of 4 quarters · filed 2021-02-11 | ||||
| 2019-06-30 | 91.10M shares 10-Q · filed 2020-07-28 | 90.70M shares 10-Q · filed 2020-07-28 | 88.77M shares derived: average of 3 quarters · filed 2021-02-11 | 89.15M shares derived: average of 4 quarters · filed 2021-02-11 | ||||
| 2019-03-31 | 90.30M shares 10-Q · filed 2020-04-28 | 87.60M shares derived: average of 2 quarters · filed 2021-02-11 | 88.50M shares derived: average of 3 quarters · filed 2021-02-11 | 88.72M shares derived: average of 4 quarters · filed 2021-02-11 | ||||
| 2018-12-31 | 84.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | 87.60M shares derived: average of 2 quarters · filed 2021-02-11 | 88.20M shares derived: average of 3 quarters · filed 2021-02-11 | 88.20M shares 10-K · filed 2021-02-11 | ||||
| 2018-09-30 | 90.30M shares 10-Q · filed 2019-11-06 | 89.85M shares derived: average of 2 quarters · filed 2019-11-06 | 89.30M shares 10-Q · filed 2019-11-06 | |||||
| 2018-06-30 | 89.40M shares 10-Q · filed 2019-07-31 | 88.80M shares 10-Q · filed 2019-07-31 | ||||||
| 2017-12-31 | 86.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | 86.80M shares derived: average of 2 quarters · filed 2020-02-13 | 87.00M shares derived: average of 3 quarters · filed 2020-02-13 | 86.30M shares 10-K · filed 2020-02-13 | ||||
| 2017-09-30 | 86.70M shares 10-Q · filed 2018-11-06 | 87.05M shares derived: average of 2 quarters · filed 2018-11-06 | 86.10M shares 10-Q · filed 2018-11-06 | |||||
| 2017-06-30 | 87.40M shares 10-Q · filed 2018-08-01 | 85.80M shares 10-Q · filed 2018-08-01 | ||||||
| 2016-06-30 | 83.60M shares 10-Q · filed 2017-08-01 | 82.80M shares 10-Q · filed 2017-08-01 | ||||||
| 2015-09-30 | 80.50M shares 10-Q · filed 2015-11-04 | 80.05M shares derived: average of 2 quarters · filed 2015-11-04 | 79.20M shares 10-Q · filed 2015-11-04 | |||||
| 2015-06-30 | 79.60M shares 10-Q · filed 2015-08-05 | 78.70M shares 10-Q · filed 2015-08-05 | ||||||
| 2014-09-30 | 76.10M shares 10-Q · filed 2015-11-04 | 75.70M shares derived: average of 2 quarters · filed 2015-11-04 | 75.00M shares 10-Q · filed 2015-11-04 | |||||
| 2014-06-30 | 75.30M shares 10-Q · filed 2015-08-05 | 74.20M shares 10-Q · filed 2015-08-05 | ||||||
| 2013-09-30 | 71.40M shares 10-Q · filed 2014-11-06 | 71.15M shares derived: average of 2 quarters · filed 2014-11-06 | 70.70M shares 10-Q · filed 2014-11-06 | |||||
| 2013-06-30 | 70.90M shares 10-Q · filed 2014-08-06 | 70.30M shares 10-Q · filed 2014-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |